Menarini / Clinical studies / Clinical trial results
 
Italiano - Contact us - Sitemap
Clinical studies
Clinical trial results

Code Title Intervention Sponsor Therapeutic
Indication
NEB-01/99-CH

Changes in Peak Respiratory Flow and quality of Life during nebivolol therapy


Nebivolol

Menarini Switzerland

Hypertension
NEB/CLIN/CH-12/99

Beta-blockade with nebivolol enhances
the acetylcholine-induced cutaneous
vasodilatation


Nebivolol versus Atenolol

Menarini Switzerland

Healthy Volunteers
MK1MEN

A comparison of the beta1-selecivity
of three beta1-selective MK1MEN
beta-blockers


Nevivolol versus Atenolol, Bisoprolol

Menarini Pharmaceutical U.K.

Healthy Volunteers
NEB/RP/02

Evaluation of the efficacy and tolerability
of nebivolol versus lisinopril in the treatment of essential arterial
hypertension: a randomized, multicentre,double-blind study


Nebivolol versus Lisinopril

Menarini Ifr

Hypertension
NEB/CLIN/NL-3/97

Comparison of effect on systolic and diastolic left ventricular function
of Nebivolol versus Atenolol in patients with uncomplicated essential hypertension


Nebivolol versus Atenolol, Bisoprolol

Menarini Benelux

Hypertension
MR/01-99/01-NHF

Randomized trial to determine the effectof nebivolol on mortality and
cardiovascular hospital admission in elderly patients with heart failure
(SENIORS)


Nebivolol from 1,25 to 10mg/day

Menarini Ricerche

Heart Failure
IC03/00/DXP

Comparison of intravenous dexketoprofen and dipyrone in acute renal colic


phase I : Dexketoprofen trometamol 25 mg intravenous route Dexketoprofen 50 mg intravenus route versus Dipyrone 2g/5ml; phase II Dexketoprofen trometamol Dipyrone 575 mg

Laboratorios Menarini S.A

Acute Renal Colic
MeAR/03/Neb-End/001

A single center, open study of Nebilet 5 mg to evaluate the change in the cold test as a marker of the endothelial dysfunction change (EDEN I)


Nebivolol,
5 mg

Laboratorios Menarini Argentina S.A.

Hypertension